文献速递免疫规划慢病防控与筛查

23价肺炎球菌多糖疫苗与季节性流感疫苗对老年人肺炎的有效性——病例对照研究中对照的选择

Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
PubMed 文献 · Vaccine · 2017-01-01

该病例对照研究于2009年10月1日至2014年9月30日开展,纳入234例≥65岁新诊断肺炎病例,按性别、年龄、就诊日期和就诊医院匹配438名对照(每例两名为其他疾病患者,一名呼吸内科、一名非呼吸内科)。未检测到肺炎球菌疫苗或流感疫苗对肺炎的有效性;仅用呼吸内科对照时肺炎球菌疫苗OR为0.59(95%CI 0.34-1.03,P=0.064)、流感疫苗OR为0.64(95%CI 0.40-1.04,P=0.072),作者认为可能因对照选择偏倚而高估。

要点

  • 未检测到PPSV23或季节性流感疫苗对老年人肺炎的有效性。
  • 仅用呼吸内科对照时肺炎球菌疫苗OR 0.59(95%CI 0.34-1.03,P=0.064)。
  • 仅用非呼吸内科对照时肺炎球菌疫苗OR接近1。

核心结论

  • 未检测到肺炎球菌疫苗或流感疫苗对肺炎的有效性;仅用呼吸内科对照分析显示边际显著有效性,但可能因对照选择偏倚被高估。
  • 作者认为选择对照时应考虑影响医生推荐接种的背景因素(基础疾病、临床科室等)。

研究设计与样本

  • 病例对照研究,研究期间为2009年10月1日至2014年9月30日。
  • 病例为≥65岁新诊断肺炎患者;每例匹配两名其他疾病对照(一名呼吸内科、一名非呼吸内科),按性别、年龄、就诊日期和就诊医院匹配。
  • 分析纳入234例病例和438名对照,使用条件logistic回归模型计算接种对肺炎的OR及95%CI。

主要发现

  • 未检测到肺炎球菌疫苗接种或流感疫苗接种对肺炎的有效性。
  • 对照中呼吸内科的接种比例高于非呼吸内科:肺炎球菌疫苗38% vs 23%,流感疫苗55% vs 48%。
  • 仅用呼吸内科对照时,肺炎球菌疫苗OR为0.59(95%CI 0.34-1.03,P=0.064),流感疫苗OR为0.64(95%CI 0.40-1.04,P=0.072)。
  • 仅用非呼吸内科对照时,肺炎球菌疫苗对肺炎的OR接近1。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 仅用呼吸内科对照显示的有效性可能因对照选择偏倚被高估,因为肺炎病例不一定是呼吸内科患者。
  • 仅用非呼吸内科对照时肺炎球菌疫苗OR接近1,推测是因为病例中肺炎球菌疫苗接种比例高于对照。
  • 研究期间肺炎球菌疫苗未常规接种,不同临床科室医生接种推荐差异可能极大影响接种比例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We conducted a case-control study to elucidate associations between pneumonia in elderly individuals and 23-valent pneumococcal polysaccharide vaccine (PPSV23) and seasonal influenza vaccine (influenza vaccine). Here, we examined selection of controls in our study using an analytic epidemiology approach. The study period was from October 1, 2009 through September 30, 2014. Cases comprised ≥65-year-old patients newly diagnosed with pneumonia. For every case with pneumonia, two patients with other diseases (one respiratory medicine, one non-respiratory medicine) who were sex-, age-, visit date- and visit hospital-matched were selected as controls. Odds ratios (ORs) and 95% confidence intervals (CIs) of vaccination for pneumonia were calculated using conditional logistic regression model. Similar analyses were also conducted based on the clinical department of controls. Analysis was conducted in 234 cases and 438 controls. Effectiveness of pneumococcal vaccination or influenza vaccination against pneumonia was not detected. Proportions of either vaccination in controls were greater among respiratory medicine (pneumococcal vaccine, 38%; influenza vaccine, 55%) than among non-respiratory medicine (23%; 48%). Analysis using controls restricted to respiratory medicine showed marginally significant effectiveness of pneumococcal vaccination (OR, 0.59; 95%CI, 0.34-1.03; P=0.064) and influenza vaccination (0.64; 0.40-1.04; 0.072). However, this effectiveness might have been overestimated by selection bias of controls, as pneumonia cases are not necessarily respiratory medicine patients. In the analysis using controls restricted to non-respiratory medicine, OR of pneumococcal vaccination for pneumonia was close to 1, presumably because the proportion of pneumococcal vaccination was higher in cases than in controls. Because pneumococcal vaccine was not routinely administered during the study period, differences in recommendations of vaccination by physician in different clinical departments might have greatly affected vaccination proportions. When we select controls, we should consider the background factors (underlying diseases, clinical department, etc.) which affect physicians' recommendation of vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kondo K, Suzuki K, Washio M, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study. Vaccine. 2017. PMID: 28818473. doi:10.1016/j.vaccine.2017.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。